Barbara Kosacz - Feb 14, 2024 Form 4 Insider Report for PHOENIX BIOTECH ACQUISITION CORP. (CERO)

Role
Director
Signature
/s/ Chris Ehrlich, Attorney-in-Fact
Stock symbol
CERO
Transactions as of
Feb 14, 2024
Transactions value $
$0
Form type
4
Date filed
2/16/2024, 07:40 PM
Previous filing
Jan 5, 2024
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERO Class A Common Stock Other +5.83K 5.83K Feb 14, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Barbara Kosacz is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock distributed in-kind by Phoenix Biotech Sponsor, LLC (the "Sponsor") to its members, pro rata and without consideration.